PW Medtech (01358) Announces No Change in Issued Shares and Reports Latest Share Repurchase

Bulletin Express

Yesterday

PW Medtech Group Limited (01358) released a Next Day Disclosure Return dated 20 February 2026, confirming that its total number of issued shares remains at 1.47 billion. The company also disclosed the ongoing status of its share repurchase program, highlighting multiple repurchases that have not yet been cancelled.

According to the announcement, a further 53,000 shares were repurchased on 20 February 2026 at prices ranging from HKD1.34 to HKD1.35, resulting in an aggregate payment of HKD71,380. Under a repurchase mandate dated 10 June 2025, the company is authorized to repurchase up to 148.67 million shares; as of the latest update, 18.49 million shares (approximately 1.24% of the issued share base at the time of the resolution) have been repurchased. The announcement also notes a moratorium on any new share issuance until 22 March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1171968768"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1171968768\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1171968768?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-20 18:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171968768","market":"us","top_or_hot":-1,"title":"PW Medtech (01358) Announces No Change in Issued Shares and Reports Latest Share Repurchase","media":"Bulletin Express","content":"<p>PW Medtech Group Limited (01358) released a Next Day Disclosure Return dated 20 February 2026, confirming that its total number of issued shares remains at 1.47 billion. The company also disclosed the ongoing status of its share repurchase program, highlighting multiple repurchases that have not yet been cancelled.</p>\n<p>According to the announcement, a further 53,000 shares were repurchased on 20 February 2026 at prices ranging from HKD1.34 to HKD1.35, resulting in an aggregate payment of HKD71,380. Under a repurchase mandate dated 10 June 2025, the company is authorized to repurchase up to 148.67 million shares; as of the latest update, 18.49 million shares (approximately 1.24% of the issued share base at the time of the resolution) have been repurchased. The announcement also notes a moratorium on any new share issuance until 22 March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PW Medtech (01358) Announces No Change in Issued Shares and Reports Latest Share Repurchase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPW Medtech (01358) Announces No Change in Issued Shares and Reports Latest Share Repurchase\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-20 18:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PW Medtech Group Limited (01358) released a Next Day Disclosure Return dated 20 February 2026, confirming that its total number of issued shares remains at 1.47 billion. The company also disclosed the ongoing status of its share repurchase program, highlighting multiple repurchases that have not yet been cancelled.</p>\n<p>According to the announcement, a further 53,000 shares were repurchased on 20 February 2026 at prices ranging from HKD1.34 to HKD1.35, resulting in an aggregate payment of HKD71,380. Under a repurchase mandate dated 10 June 2025, the company is authorized to repurchase up to 148.67 million shares; as of the latest update, 18.49 million shares (approximately 1.24% of the issued share base at the time of the resolution) have been repurchased. The announcement also notes a moratorium on any new share issuance until 22 March 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01358","symbol_name":"普华和顺","start_time":0,"source_url":"","article_id":"1171968768","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171968768","pubTimestamp":1771582901,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"PW Medtech Group Limited (01358) released a Next Day Disclosure Return dated 20 February 2026, confirming that its total number of issued shares remains at 1.47 billion. The company also disclosed...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01358":"普华和顺"},"translate_title":"普华永道(01358)公布已发行股份无变动及报告最新股份购回","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01358":1},"content_text":"PW Medtech Group Limited (01358) released a Next Day Disclosure Return dated 20 February 2026, confirming that its total number of issued shares remains at 1.47 billion. The company also disclosed the ongoing status of its share repurchase program, highlighting multiple repurchases that have not yet been cancelled.\nAccording to the announcement, a further 53,000 shares were repurchased on 20 February 2026 at prices ranging from HKD1.34 to HKD1.35, resulting in an aggregate payment of HKD71,380. Under a repurchase mandate dated 10 June 2025, the company is authorized to repurchase up to 148.67 million shares; as of the latest update, 18.49 million shares (approximately 1.24% of the issued share base at the time of the resolution) have been repurchased. The announcement also notes a moratorium on any new share issuance until 22 March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}